carmustine has been researched along with Dysesthesia in 4 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Excerpt | Relevance | Reference |
---|---|---|
"We describe seven patients who developed symptoms including severe headache, circumoral paresthesia, and facial flushing during high-dose carmustine (BCNU) infusion as part of the preparative regimen for autologous peripheral blood stem cell (PBSC) transplantation for metastatic breast cancer." | 7.69 | Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion. ( Bruton, J; Champlin, R; Ippoliti, C; Mehra, R; Przepiorka, D; Woo, MH, 1997) |
"We describe seven patients who developed symptoms including severe headache, circumoral paresthesia, and facial flushing during high-dose carmustine (BCNU) infusion as part of the preparative regimen for autologous peripheral blood stem cell (PBSC) transplantation for metastatic breast cancer." | 3.69 | Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion. ( Bruton, J; Champlin, R; Ippoliti, C; Mehra, R; Przepiorka, D; Woo, MH, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Otrock, ZK | 1 |
Beydoun, A | 1 |
Barada, WM | 1 |
Masroujeh, R | 1 |
Hourani, R | 1 |
Bazarbachi, A | 1 |
Kempin, S | 1 |
Lee, BJ | 1 |
Thaler, HT | 1 |
Koziner, B | 1 |
Hecht, S | 1 |
Gee, T | 1 |
Arlin, Z | 1 |
Little, C | 1 |
Straus, D | 1 |
Reich, L | 1 |
Phillips, E | 1 |
Al-Mondhiry, H | 1 |
Dowling, M | 1 |
Mayer, K | 1 |
Clarkson, B | 1 |
Woo, MH | 1 |
Ippoliti, C | 1 |
Bruton, J | 1 |
Mehra, R | 1 |
Champlin, R | 1 |
Przepiorka, D | 1 |
Fewer, D | 1 |
Wilson, CB | 1 |
Boldrey, EB | 1 |
Enot, KJ | 1 |
Powell, MR | 1 |
1 review available for carmustine and Dysesthesia
Article | Year |
---|---|
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; | 1982 |
1 trial available for carmustine and Dysesthesia
Article | Year |
---|---|
The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine.
Topics: Astrocytoma; Brain Neoplasms; Carcinosarcoma; Carmustine; Cerebral Angiography; Ependymoma; Evaluati | 1972 |
2 other studies available for carmustine and Dysesthesia
Article | Year |
---|---|
Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Topics: Adult; Alkalosis, Respiratory; Amnesia, Retrograde; Amnesia, Transient Global; Antineoplastic Combin | 2008 |
Headache, circumoral paresthesia, and facial flushing associated with high-dose carmustine infusion.
Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Ductal, Breast; Carmustine; Cytokine | 1997 |